Endoscopic Classification of Fundoplication Integrity Predicts Pathologic Reflux
Key facts
- Who runs it
- IRCCS Policlinico S. Donato
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 153 people enrolled
- Started
- 1 Apr 2018
- Ended
- 1 Jul 2026
- Type of study
- Observational, 3 groups
- Record updated
- 27 July 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Adults (18-90 years)
- Previous Nissen or Toupet fundoplication for GERD or large hiatal hernia
- Completion of post-operative esophagogastroduodenoscopy (EGD)
- Adequate retroflexed endoscopic videoclip
- Post-operative High-resolution manometry (HRM) and reflux monitoring (MII-pH or wireless pH)
Who cannot take part
- Other foregut operations (Dor, Collis, magnetic sphincter augmentation, bariatric surgery)
- Insufficient quality of endoscopic videoclips
- Missing HRM or reflux monitoring
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This single-center, two-phase cohort study aimed to develop and validate a simple endoscopic classification of fundoplication integrity after anti-reflux surgery (ARS - Nissen or Toupet fundoplication). Consecutive adult patients undergoing endoscopy, high-resolution manometry (HRM), and reflux monitoring after ARS were included. Retroflexed endoscopic videoclips were reviewed blinded to clinical and functional results. In the development cohort (2018-2024, n=73), individual endoscopic parameters were tested against pathologic GERD (Lyon 2.0 criteria). Three parameters significantly correlated with pathologic reflux: (1) intrathoracic valve location, (2) disrupted valve (deep anterior and/or posterior grooves), and (3) visible hiatal opening. Patients were stratified according to the number of impaired mechanisms (0-3). Symptom burden, manometric abnormalities, and reflux metrics worsened progressively with increasing impairment. The rate of pathologic GERD rose from 11.8% (0 mechanisms) to 37.5% (1-2 mechanisms) to 85.7% (3 mechanisms). The classification was then prospectively validated in an independent cohort (2024-2026, n=49), reproducing the same stepwise correlation. The number of impaired mechanisms showed excellent discriminatory capacity for pathologic GERD (AUC 0.860 in development, 0.870 in validation; overall AUC 0.869). This simple endoscopic classification, based on only three objective parameters, reliably identifies fundoplication failure and correlates with symptoms and objective pathophysiologic data. It has the potential to standardize endoscopic reporting after ARS.
The 3 groups in the trial
- Normal fundoplication
Patients with 0 impaired mechanisms of ARB restoration
- Partially impaired fundoplication
Patients with 1-2 impaired mechanisms of ARB restoration
- Fully impaired fundoplication
Patients with 3 impaired mechanisms of ARB restoration
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- ENDOSCOPIC CLASSIFICATION OF FUNDOPLICATION INTEGRITY PREDICTS PATHOLOGIC REFLUX: DEVELOPMENT AND PROSPECTIVE VALIDATION
- Record updated
- 27 July 2026